Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Platelet-rich plasma may help hair follicle cells grow by affecting certain genes and pathways.

Hair loss in children can be caused by fungal infections, trauma, autoimmune disorders, or stress, and treatments vary depending on the cause.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

The document doesn't say if the treatment for hair loss worked.

The exact cause of frontal fibrosing alopecia is unknown, but it's not likely due to sunscreen.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

An 8-year-old boy had both alopecia areata and vitiligo on the same spot on his scalp, which is very rare.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

Large doses of glucocorticoids are not suitable for general use in treating severe alopecia areata due to inconsistent results and risks.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

A 22-year-old with multiple autoimmune diseases needs a multidisciplinary treatment approach.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Marijuana use may be linked to lower TSH levels, but the exact cause is unclear.

Cyclosporine can treat skin conditions but needs careful monitoring for side effects.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.